152 related articles for article (PubMed ID: 20688085)
21. Glucose tolerance and insulin action in monosodium glutamate (MSG) obese exercise-trained rats.
de Mello MA; de Souza CT; Braga LR; dos Santos JW; Ribeiro IA; Gobatto CA
Physiol Chem Phys Med NMR; 2001; 33(1):63-71. PubMed ID: 11758736
[TBL] [Abstract][Full Text] [Related]
22. Vagotomy reduces obesity in MSG-treated rats.
Balbo SL; Mathias PC; Bonfleur ML; Alves HF; Siroti FJ; Monteiro OG; Ribeiro FB; Souza AC
Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):291-6. PubMed ID: 11958282
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2 inhibition normalizes arterial blood pressure in CYP1A1-REN2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Opay AL; Mouton CR; Mullins JJ; Mitchell KD
Am J Physiol Renal Physiol; 2006 Sep; 291(3):F612-8. PubMed ID: 16622181
[TBL] [Abstract][Full Text] [Related]
24. Effects of monosodium glutamate-induced obesity in spontaneously hypertensive rats vs. Wistar Kyoto rats: serum leptin and blood flow to brown adipose tissue.
Iwase M; Ichikawa K; Tashiro K; Iino K; Shinohara N; Ibayashi S; Yoshinari M; Fujishima M
Hypertens Res; 2000 Sep; 23(5):503-10. PubMed ID: 11016806
[TBL] [Abstract][Full Text] [Related]
25. Effect of food restriction on energy expenditure of monosodium glutamate-induced obese rats.
Luz J; Pasin VP; Silva DJ; Zemdegs JC; Amaral LS; Affonso-Silva SM
Ann Nutr Metab; 2010; 56(1):31-5. PubMed ID: 20016145
[TBL] [Abstract][Full Text] [Related]
26. The monosodium glutamate (MSG) obese rat as a model for the study of exercise in obesity.
Gobatto CA; Mello MA; Souza CT; Ribeiro IA
Res Commun Mol Pathol Pharmacol; 2002; 111(1-4):89-101. PubMed ID: 14632317
[TBL] [Abstract][Full Text] [Related]
27. Nitrogen metabolism in obesity induced by monosodium-L-glutamate in rats.
Betrán MA; Estornell E; Barber T; Cabo J
Int J Obes Relat Metab Disord; 1992 Aug; 16(8):555-64. PubMed ID: 1326485
[TBL] [Abstract][Full Text] [Related]
28. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats.
Silambarasan T; Raja B
Eur J Pharmacol; 2012 Mar; 679(1-3):81-9. PubMed ID: 22266490
[TBL] [Abstract][Full Text] [Related]
29. Effects of stem bark aqueous extract of Fagara tessmannii Engl (Rutaceae) on cardiovascular risks related to monosodium glutamate-induced obesity in rat: In vivo and in vitro assessments.
Fouda YB; Ngo Lemba Tom E; Atsamo AD; Bonabe C; Dimo T
J Ethnopharmacol; 2020 Oct; 260():112972. PubMed ID: 32446928
[TBL] [Abstract][Full Text] [Related]
30. Suppressive effect of COX2 inhibitor on the progression of adipose inflammation in high-fat-induced obese rats.
Hsieh PS; Lu KC; Chiang CF; Chen CH
Eur J Clin Invest; 2010 Feb; 40(2):164-71. PubMed ID: 20039930
[TBL] [Abstract][Full Text] [Related]
31. Perinatal MSG treatment attenuates fasting-induced bradycardia and metabolic suppression.
Messina MM; Evans SA; Swoap SJ; Overton JM
Physiol Behav; 2005 Oct; 86(3):324-30. PubMed ID: 16153669
[TBL] [Abstract][Full Text] [Related]
32. Celecoxib, a selective cyclooxygenase-2 inhibitor, lowers plasma cholesterol and attenuates hepatic lipid peroxidation during carbon-tetrachloride-associated hepatotoxicity in rats.
Ekor M; Odewabi AO; Kale OE; Adesanoye OA; Bamidele TO
Drug Chem Toxicol; 2013 Jan; 36(1):1-8. PubMed ID: 22168377
[TBL] [Abstract][Full Text] [Related]
33. The role of selective nitric oxide synthase inhibitor on nitric oxide and PGE2 levels in refractory hemorrhagic-shocked rats.
Md S; Moochhala SM; Siew Yang KL; Lu J; Anuar F; Mok P; Ng KC
J Surg Res; 2005 Feb; 123(2):206-14. PubMed ID: 15680380
[TBL] [Abstract][Full Text] [Related]
34. Effects of fibre-enriched diets on tissue lipid profiles of MSG obese rats.
Rotimi OA; Olayiwola IO; Ademuyiwa O; Balogun EA
Food Chem Toxicol; 2012 Nov; 50(11):4062-7. PubMed ID: 22898616
[TBL] [Abstract][Full Text] [Related]
35. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
Tang BD; Zeng ZR; Hu PJ
Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761
[TBL] [Abstract][Full Text] [Related]
36. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor.
Muscará MN; McKnight W; Asfaha S; Wallace JL
Br J Pharmacol; 2000 Feb; 129(4):681-6. PubMed ID: 10683192
[TBL] [Abstract][Full Text] [Related]
37. The effects of some nonsteroidal anti-inflammatory drugs on experimental induced gastric ulcers in rats.
Batu OS; Erol K
Inflammopharmacology; 2007 Dec; 15(6):260-5. PubMed ID: 18236017
[TBL] [Abstract][Full Text] [Related]
38. Neutral aminopeptidase and dipeptidyl peptidase IV activities in plasma of monosodium glutamate obese and food-deprived rats.
Alponti RF; Silveira PF
Obesity (Silver Spring); 2010 Jul; 18(7):1312-7. PubMed ID: 19876009
[TBL] [Abstract][Full Text] [Related]
39. Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain.
Guo JY; Li CY; Ruan YP; Sun M; Qi XL; Zhao BS; Luo F
Eur J Pharmacol; 2009 Jun; 612(1-3):54-60. PubMed ID: 19356723
[TBL] [Abstract][Full Text] [Related]
40. Taurine prevents fat deposition and ameliorates plasma lipid profile in monosodium glutamate-obese rats.
Nardelli TR; Ribeiro RA; Balbo SL; Vanzela EC; Carneiro EM; Boschero AC; Bonfleur ML
Amino Acids; 2011 Oct; 41(4):901-8. PubMed ID: 21042817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
